Small heat shock protein HspX (Hsp16.3)

Small heat shock protein HspX (Hsp16.3) is a critical molecular chaperone produced by Mycobacterium tuberculosis and related mycobacteria, belonging to the alpha-crystallin family. It is one of the most abundantly expressed proteins during the stationary phase and under hypoxic conditions, playing a vital role in the pathogen's ability to enter and survive in a dormant or latent state within the host. By preventing the irreversible aggregation of essential proteins and contributing to cell wall thickening, Hsp16.3 ensures bacterial persistence against environmental stresses and host immune defenses. In addition to its structural and protective roles, Hsp16.3 modulates host immunity by promoting M2 macrophage polarization, which creates an immunosuppressive microenvironment conducive to long-term infection. Because of its unique expression profile during latency and its high immunogenicity, it is a major target for the development of next-generation tuberculosis vaccines and diagnostic tools. Current therapeutic research focuses on identifying small molecule or peptide inhibitors that can disrupt its chaperone function, potentially providing a way to eradicate persistent mycobacterial populations that are otherwise resistant to conventional antibiotics.

Other names

16 kDa antigenAlpha-crystallin homologAcr1Rv2031cAntigen C16HspX

Hsp16.3 acts as a molecular chaperone that prevents the aggregation of denatured proteins during stress; therapeutic inhibitors aim to disrupt this chaperone activity to impair mycobacterial survival during dormancy, while vaccines utilize its high immunogenicity to induce a protective Th1 immune response.